Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Novartis Announced Data Supporting Upcoming Regulatory Filings for Tislelizumab in People With Squamous and Non-squamous Non-small Cell Lung Cancer, and for Alpelisib in People With PIK3CA-related Overgrowth Spectrum at ESMO

Novartis (NYSE: NVS) will present new data from its robust portfolio and pipeline of advanced therapeutic platforms in solid tumors, with more than 55 abstracts from Novartis-sponsored and investigator-initiated trials accepted at the upcoming European Society for Medical Oncology (ESMO) Congress 2021.

NVS

Read More

AcelRx To Present On Effect Of Administration Of Sufentanil Sublingual Tablet On Reducing Post-Operative Recovery Time And Opioid Use In Plastic Surgery At The Annual Miami Cosmetic Surgery Event Aug. 27

AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today

ACRX